{"nct_id":"NCT05178862","title":"A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2022-08-03","start_date_type":"ACTUAL","primary_completion_date":"2026-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SCYX"]}